171 related articles for article (PubMed ID: 33864178)
1. Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China.
Wang T; Ying M; Zhao R; Zhu D; Zhang L
Sleep Breath; 2022 Mar; 26(1):373-380. PubMed ID: 33864178
[TBL] [Abstract][Full Text] [Related]
2. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).
Winkelman JW; Johnston L
Sleep Med; 2004 Jan; 5(1):9-14. PubMed ID: 14725821
[TBL] [Abstract][Full Text] [Related]
3. Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study.
Takahashi M; Nishida S; Nakamura M; Kobayashi M; Matsui K; Ito E; Usui A; Inoue Y
PLoS One; 2017; 12(3):e0173535. PubMed ID: 28264052
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
[TBL] [Abstract][Full Text] [Related]
5. Pramipexole in the management of restless legs syndrome: an extended study.
Silber MH; Girish M; Izurieta R
Sleep; 2003 Nov; 26(7):819-21. PubMed ID: 14655914
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pregabalin with pramipexole for restless legs syndrome.
Allen RP; Chen C; Garcia-Borreguero D; Polo O; DuBrava S; Miceli J; Knapp L; Winkelman JW
N Engl J Med; 2014 Feb; 370(7):621-31. PubMed ID: 24521108
[TBL] [Abstract][Full Text] [Related]
7. High national rates of high-dose dopamine agonist prescribing for restless legs syndrome.
Winkelman JW
Sleep; 2022 Feb; 45(2):. PubMed ID: 34417810
[TBL] [Abstract][Full Text] [Related]
8. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
Geyer J; Bogan R
Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
[TBL] [Abstract][Full Text] [Related]
9. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
Bayard S; Langenier MC; Dauvilliers Y
Sleep; 2013 Oct; 36(10):1501-7. PubMed ID: 24082309
[TBL] [Abstract][Full Text] [Related]
10. Long-term use of pramipexole in the management of restless legs syndrome.
Lipford MC; Silber MH
Sleep Med; 2012 Dec; 13(10):1280-5. PubMed ID: 23036265
[TBL] [Abstract][Full Text] [Related]
11. A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
Winkelman JW; Mackie SE; Mei LA; Platt S; Schoerning L
Sleep Med; 2016 Aug; 24():18-23. PubMed ID: 27810181
[TBL] [Abstract][Full Text] [Related]
12. Augmentation in restless legs syndrome patients in Korea.
Jeon JY; Moon HJ; Song ML; Lee HB; Cho YW
Sleep Breath; 2015 May; 19(2):523-9. PubMed ID: 25082663
[TBL] [Abstract][Full Text] [Related]
13. Pramipexole in the treatment of restless legs syndrome: a follow-up study.
Montplaisir J; Denesle R; Petit D
Eur J Neurol; 2000 May; 7 Suppl 1():27-31. PubMed ID: 11054156
[TBL] [Abstract][Full Text] [Related]
14. Restless legs syndrome: differential diagnosis and management with pramipexole.
Brindani F; Vitetta F; Gemignani F
Clin Interv Aging; 2009; 4():305-13. PubMed ID: 19750232
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
[TBL] [Abstract][Full Text] [Related]
16. Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?
Rocchi C; Albanese M; Placidi F; Romigi A; Lauretti B; Marfia GA; Liguori C; Marciani MG; Mercuri NB; Izzi F
Sleep Med; 2015 Sep; 16(9):1071-6. PubMed ID: 26298781
[TBL] [Abstract][Full Text] [Related]
17. Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.
Maestri M; Fulda S; Ferini-Strambi L; Zucconi M; Marelli S; Staedler C; Bassetti CL; Manconi M
Sleep Med; 2014 May; 15(5):570-5. PubMed ID: 24767724
[TBL] [Abstract][Full Text] [Related]
18. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin.
Lee CS; Lee SD; Kang SH; Park HY; Yoon IY
Eur J Neurol; 2014 Feb; 21(2):260-6. PubMed ID: 24267148
[TBL] [Abstract][Full Text] [Related]
20. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]